APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nystatin

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Nystatin Market Outlook and Growth Opportunities 2026

23 December 2025211 pages

Choose your research edition.

Industry ResearchNystatin Industry Research Report 2026150 pages · $2,950 USDIndustry Growth & TrendsGlobal Nystatin Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Nystatin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nystatin Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal Nystatin Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global Nystatin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Nystatin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nystatin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nystatin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Nystatin market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Nystatin market include 3B Scientific, BeiJing Hwrk Chemicals, Beijing NuoqiYa Biotechnology, BEST-REAGENT, BOC Sciences, Fishfa Biogenics, HBCChem, J & K SCIENTIFIC and LGM Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Nystatin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nystatin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nystatin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nystatin market size, projected growth trends, production technologies, key applications, and end-use industries.

Nystatin Segment by Company

3B Scientific

BeiJing Hwrk Chemicals

Beijing NuoqiYa Biotechnology

BEST-REAGENT

BOC Sciences

Fishfa Biogenics

HBCChem

J & K SCIENTIFIC

LGM Pharma

Pure Chemistry Scientific

Toronto Research Chemicals

Waterstone Technology

XiaoGan ShenYuan ChemPharm

Olon S.p.A

Guangzhou Tosun Pharmaceutical

Pfizer

Concord Biotech

BrightGene Bio-Medical Technology

Antibiotice SA

Shanghai Minbiotech

Zhejiang Huida Biotech

Centrient Pharmaceuticals

Nystatin Segment by Type

USP Grade

Research Grade

Others

Nystatin Segment by Application

Skin

Oral Cavity

Others

Nystatin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Nystatin status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Nystatin market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Nystatin significant trends, drivers, influence factors in global and regions.

6. To analyze Nystatin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nystatin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nystatin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nystatin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nystatin market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nystatin industry.

Chapter 3: Detailed analysis of Nystatin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Nystatin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Nystatin in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Nystatin Industry Trends Table 2. Nystatin Industry Drivers Table 3. Nystatin Industry Opportunities and Challenges Table 4. Nystatin Industry Restraints Table 5. Global Nystatin Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Nystatin Revenue Share by Company (2021-2026) Table 7. Global Nystatin Sales Volume by Company (t) & (2021-2026) Table 8. Global Nystatin Sales Volume Share by Company (2021-2026) Table 9. Global Nystatin Average Price (USD/t) of Company (2021-2026) Table 10. Global Nystatin Company Ranking, (2024-2026) & (USD Million) Table 11. Global Nystatin Key Company Manufacturing Base & Headquarters Table 12. Global Nystatin Company, Product Type & Application Table 13. Global Nystatin Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Nystatin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of USP Grade Table 18. Significant Companies of Research Grade Table 19. Significant Companies of Others Table 20. Global Nystatin Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 21. Global Nystatin Sales Volume by Type (2021-2026) & (t) Table 22. Global Nystatin Sales Volume by Type (2027-2032) & (t) Table 23. Global Nystatin Sales Volume Share by Type (2021-2026) Table 24. Global Nystatin Sales Volume Share by Type (2027-2032) Table 25. Global Nystatin Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Nystatin Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Nystatin Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Nystatin Sales Value Share by Type (2021-2026) Table 29. Global Nystatin Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Skin Table 31. Significant Companies of Oral Cavity Table 32. Significant Companies of Others Table 33. Global Nystatin Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 34. Global Nystatin Sales Volume by Application (2021-2026) & (t) Table 35. Global Nystatin Sales Volume by Application (2027-2032) & (t) Table 36. Global Nystatin Sales Volume Share by Application (2021-2026) Table 37. Global Nystatin Sales Volume Share by Application (2027-2032) Table 38. Global Nystatin Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Nystatin Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Nystatin Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Nystatin Sales Value Share by Application (2021-2026) Table 42. Global Nystatin Sales Value Share by Application (2027-2032) Table 43. Global Nystatin Sales by Region: 2021 VS 2025 VS 2032 (t) Table 44. Global Nystatin Sales by Region (2021-2026) & (t) Table 45. Global Nystatin Sales Market Share by Region (2021-2026) Table 46. Global Nystatin Sales by Region (2027-2032) & (t) Table 47. Global Nystatin Sales Market Share by Region (2027-2032) Table 48. Global Nystatin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Nystatin Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Nystatin Sales Value Share by Region (2021-2026) Table 51. Global Nystatin Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Nystatin Sales Value Share by Region (2027-2032) Table 53. Global Nystatin Market Average Price (USD/t) by Region (2021-2026) Table 54. Global Nystatin Market Average Price (USD/t) by Region (2027-2032) Table 55. Global Nystatin Sales by Country: 2021 VS 2025 VS 2032 (t) Table 56. Global Nystatin Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Nystatin Sales by Country (2021-2026) & (t) Table 58. Global Nystatin Sales Market Share by Country (2021-2026) Table 59. Global Nystatin Sales by Country (2027-2032) & (t) Table 60. Global Nystatin Sales Market Share by Country (2027-2032) Table 61. Global Nystatin Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Nystatin Sales Value Market Share by Country (2021-2026) Table 63. Global Nystatin Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Nystatin Sales Value Market Share by Country (2027-2032) Table 65. 3B Scientific Company Information Table 66. 3B Scientific Business Overview Table 67. 3B Scientific Nystatin Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 68. 3B Scientific Nystatin Product Portfolio Table 69. 3B Scientific Recent Development Table 70. BeiJing Hwrk Chemicals Company Information Table 71. BeiJing Hwrk Chemicals Business Overview Table 72. BeiJing Hwrk Chemicals Nystatin Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 73. BeiJing Hwrk Chemicals Nystatin Product Portfolio Table 74. BeiJing Hwrk Chemicals Recent Development Table 75. Beijing NuoqiYa Biotechnology Company Information Table 76. Beijing NuoqiYa Biotechnology Business Overview Table 77. Beijing NuoqiYa Biotechnology Nystatin Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 78. Beijing NuoqiYa Biotechnology Nystatin Product Portfolio Table 79. Beijing NuoqiYa Biotechnology Recent Development Table 80. BEST-REAGENT Company Information Table 81. BEST-REAGENT Business Overview Table 82. BEST-REAGENT Nystatin Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 83. BEST-REAGENT Nystatin Product Portfolio Table 84. BEST-REAGENT Recent Development Table 85. BOC Sciences Company Information Table 86. BOC Sciences Business Overview Table 87. BOC Sciences Nystatin Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 88. BOC Sciences Nystatin Product Portfolio Table 89. BOC Sciences Recent Development Table 90. Fishfa Biogenics Company Information Table 91. Fishfa Biogenics Business Overview Table 92. Fishfa Biogenics Nystatin Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 93. Fishfa Biogenics Nystatin Product Portfolio Table 94. Fishfa Biogenics Recent Development Table 95. HBCChem Company Information Table 96. HBCChem Business Overview Table 97. HBCChem Nystatin Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 98. HBCChem Nystatin Product Portfolio Table 99. HBCChem Recent Development Table 100. J & K SCIENTIFIC Company Information Table 101. J & K SCIENTIFIC Business Overview Table 102. J & K SCIENTIFIC Nystatin Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 103. J & K SCIENTIFIC Nystatin Product Portfolio Table 104. J & K SCIENTIFIC Recent Development Table 105. LGM Pharma Company Information Table 106. LGM Pharma Business Overview Table 107. LGM Pharma Nystatin Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 108. LGM Pharma Nystatin Product Portfolio Table 109. LGM Pharma Recent Development Table 110. Pure Chemistry Scientific Company Information Table 111. Pure Chemistry Scientific Business Overview Table 112. Pure Chemistry Scientific Nystatin Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 113. Pure Chemistry Scientific Nystatin Product Portfolio Table 114. Pure Chemistry Scientific Recent Development Table 115. Toronto Research Chemicals Company Information Table 116. Toronto Research Chemicals Business Overview Table 117. Toronto Research Chemicals Nystatin Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 118. Toronto Research Chemicals Nystatin Product Portfolio Table 119. Toronto Research Chemicals Recent Development Table 120. Waterstone Technology Company Information Table 121. Waterstone Technology Business Overview Table 122. Waterstone Technology Nystatin Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 123. Waterstone Technology Nystatin Product Portfolio Table 124. Waterstone Technology Recent Development Table 125. XiaoGan ShenYuan ChemPharm Company Information Table 126. XiaoGan ShenYuan ChemPharm Business Overview Table 127. XiaoGan ShenYuan ChemPharm Nystatin Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 128. XiaoGan ShenYuan ChemPharm Nystatin Product Portfolio Table 129. XiaoGan ShenYuan ChemPharm Recent Development Table 130. Olon S.p.A Company Information Table 131. Olon S.p.A Business Overview Table 132. Olon S.p.A Nystatin Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 133. Olon S.p.A Nystatin Product Portfolio Table 134. Olon S.p.A Recent Development Table 135. Guangzhou Tosun Pharmaceutical Company Information Table 136. Guangzhou Tosun Pharmaceutical Business Overview Table 137. Guangzhou Tosun Pharmaceutical Nystatin Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 138. Guangzhou Tosun Pharmaceutical Nystatin Product Portfolio Table 139. Guangzhou Tosun Pharmaceutical Recent Development Table 140. Pfizer Company Information Table 141. Pfizer Business Overview Table 142. Pfizer Nystatin Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 143. Pfizer Nystatin Product Portfolio Table 144. Pfizer Recent Development Table 145. Concord Biotech Company Information Table 146. Concord Biotech Business Overview Table 147. Concord Biotech Nystatin Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 148. Concord Biotech Nystatin Product Portfolio Table 149. Concord Biotech Recent Development Table 150. BrightGene Bio-Medical Technology Company Information Table 151. BrightGene Bio-Medical Technology Business Overview Table 152. BrightGene Bio-Medical Technology Nystatin Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 153. BrightGene Bio-Medical Technology Nystatin Product Portfolio Table 154. BrightGene Bio-Medical Technology Recent Development Table 155. Antibiotice SA Company Information Table 156. Antibiotice SA Business Overview Table 157. Antibiotice SA Nystatin Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 158. Antibiotice SA Nystatin Product Portfolio Table 159. Antibiotice SA Recent Development Table 160. Shanghai Minbiotech Company Information Table 161. Shanghai Minbiotech Business Overview Table 162. Shanghai Minbiotech Nystatin Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 163. Shanghai Minbiotech Nystatin Product Portfolio Table 164. Shanghai Minbiotech Recent Development Table 165. Zhejiang Huida Biotech Company Information Table 166. Zhejiang Huida Biotech Business Overview Table 167. Zhejiang Huida Biotech Nystatin Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 168. Zhejiang Huida Biotech Nystatin Product Portfolio Table 169. Zhejiang Huida Biotech Recent Development Table 170. Centrient Pharmaceuticals Company Information Table 171. Centrient Pharmaceuticals Business Overview Table 172. Centrient Pharmaceuticals Nystatin Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 173. Centrient Pharmaceuticals Nystatin Product Portfolio Table 174. Centrient Pharmaceuticals Recent Development Table 175. Key Raw Materials Table 176. Raw Materials Key Suppliers Table 177. Nystatin Distributors List Table 178. Nystatin Customers List Table 179. Research Programs/Design for This Report Table 180. Authors List of This Report Table 181. Secondary Sources Table 182. Primary Sources List of Figures Figure 1. Nystatin Product Image Figure 2. Global Nystatin Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nystatin Sales Value (2021-2032) & (US$ Million) Figure 4. Global Nystatin Sales (2021-2032) & (t) Figure 5. Global Nystatin Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Nystatin Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. USP Grade Image Figure 10. Research Grade Image Figure 11. Others Image Figure 12. Global Nystatin Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 13. Global Nystatin Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Nystatin Sales Volume Share by Type (2021-2032) Figure 15. Global Nystatin Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Nystatin Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Nystatin Sales Value Share by Type (2021-2032) Figure 18. Skin Image Figure 19. Oral Cavity Image Figure 20. Others Image Figure 21. Global Nystatin Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 22. Global Nystatin Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Nystatin Sales Volume Share by Application (2021-2032) Figure 24. Global Nystatin Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Nystatin Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Nystatin Sales Value Share by Application (2021-2032) Figure 27. Global Nystatin Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 28. Global Nystatin Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Nystatin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Nystatin Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Nystatin Sales Value (2021-2032) & (US$ Million) Figure 32. North America Nystatin Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Nystatin Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Nystatin Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Nystatin Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Nystatin Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Nystatin Sales Value (2021-2032) & (US$ Million) Figure 38. South America Nystatin Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Nystatin Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Nystatin Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Nystatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Nystatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Nystatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Nystatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Nystatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Nystatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Nystatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Nystatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Nystatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Nystatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Nystatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Nystatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Nystatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Nystatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Nystatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Nystatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Nystatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Nystatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Nystatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Nystatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Nystatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Nystatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Nystatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Nystatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Nystatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Nystatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Nystatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Nystatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Nystatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Nystatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Nystatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Nystatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Nystatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Nystatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Nystatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Nystatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Nystatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Nystatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Nystatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Nystatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Nystatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Nystatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Nystatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Nystatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Nystatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Nystatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Nystatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Nystatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Nystatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Nystatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Nystatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Nystatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Nystatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Nystatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Nystatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Nystatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Nystatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Nystatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Nystatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Nystatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Nystatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Nystatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Nystatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Nystatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Nystatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Nystatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Nystatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Nystatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Nystatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Nystatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Nystatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Nystatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Nystatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Nystatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Nystatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Nystatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Nystatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Nystatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Nystatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Nystatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Nystatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Nystatin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Nystatin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Nystatin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Nystatin Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Nystatin Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • USP Grade
  • Research Grade
  • Others
Applications
  • Skin
  • Oral Cavity
  • Others
Companies covered
  • 3B Scientific
  • BeiJing Hwrk Chemicals
  • Beijing NuoqiYa Biotechnology
  • BEST-REAGENT
  • BOC Sciences
  • Fishfa Biogenics
  • HBCChem
  • J & K SCIENTIFIC
  • LGM Pharma
  • Pure Chemistry Scientific
  • Toronto Research Chemicals
  • Waterstone Technology
  • XiaoGan ShenYuan ChemPharm
  • Olon S.p.A
  • Guangzhou Tosun Pharmaceutical
  • Pfizer
  • Concord Biotech
  • BrightGene Bio-Medical Technology
  • Antibiotice SA
  • Shanghai Minbiotech
  • Zhejiang Huida Biotech
  • Centrient Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nystatin Sales Value (2021-2032)
  4. 1.2.2 Global Nystatin Sales Volume (2021-2032)
  5. 1.2.3 Global Nystatin Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Nystatin Market Dynamics
  1. 2.1 Nystatin Industry Trends
  2. 2.2 Nystatin Industry Drivers
  3. 2.3 Nystatin Industry Opportunities and Challenges
  4. 2.4 Nystatin Industry Restraints
3 Nystatin Market by Company
  1. 3.1 Global Nystatin Company Revenue Ranking in 2025
  2. 3.2 Global Nystatin Revenue by Company (2021-2026)
  3. 3.3 Global Nystatin Sales Volume by Company (2021-2026)
  4. 3.4 Global Nystatin Average Price by Company (2021-2026)
  5. 3.5 Global Nystatin Company Ranking (2024-2026)
  6. 3.6 Global Nystatin Company Manufacturing Base and Headquarters
  7. 3.7 Global Nystatin Company Product Type and Application
  8. 3.8 Global Nystatin Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Nystatin Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Nystatin Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Nystatin Market by Type
  1. 4.1 Nystatin Type Introduction
  2. 4.1.1 USP Grade
  3. 4.1.2 Research Grade
  4. 4.1.3 Others
  5. 4.2 Global Nystatin Sales Volume by Type
  6. 4.2.1 Global Nystatin Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Nystatin Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Nystatin Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Nystatin Sales Value by Type
  10. 4.3.1 Global Nystatin Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Nystatin Sales Value by Type (2021-2032)
  12. 4.3.3 Global Nystatin Sales Value Share by Type (2021-2032)
5 Nystatin Market by Application
  1. 5.1 Nystatin Application Introduction
  2. 5.1.1 Skin
  3. 5.1.2 Oral Cavity
  4. 5.1.3 Others
  5. 5.2 Global Nystatin Sales Volume by Application
  6. 5.2.1 Global Nystatin Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Nystatin Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Nystatin Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Nystatin Sales Value by Application
  10. 5.3.1 Global Nystatin Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Nystatin Sales Value by Application (2021-2032)
  12. 5.3.3 Global Nystatin Sales Value Share by Application (2021-2032)
6 Nystatin Regional Sales and Value Analysis
  1. 6.1 Global Nystatin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nystatin Sales by Region (2021-2032)
  3. 6.2.1 Global Nystatin Sales by Region: 2021-2026
  4. 6.2.2 Global Nystatin Sales by Region (2027-2032)
  5. 6.3 Global Nystatin Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Nystatin Sales Value by Region (2021-2032)
  7. 6.4.1 Global Nystatin Sales Value by Region: 2021-2026
  8. 6.4.2 Global Nystatin Sales Value by Region (2027-2032)
  9. 6.5 Global Nystatin Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Nystatin Sales Value (2021-2032)
  12. 6.6.2 North America Nystatin Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Nystatin Sales Value (2021-2032)
  15. 6.7.2 Europe Nystatin Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Nystatin Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Nystatin Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Nystatin Sales Value (2021-2032)
  21. 6.9.2 South America Nystatin Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Nystatin Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Nystatin Sales Value Share by Country, 2025 VS 2032
7 Nystatin Country-level Sales and Value Analysis
  1. 7.1 Global Nystatin Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Nystatin Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Nystatin Sales by Country (2021-2032)
  4. 7.3.1 Global Nystatin Sales by Country (2021-2026)
  5. 7.3.2 Global Nystatin Sales by Country (2027-2032)
  6. 7.4 Global Nystatin Sales Value by Country (2021-2032)
  7. 7.4.1 Global Nystatin Sales Value by Country (2021-2026)
  8. 7.4.2 Global Nystatin Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Nystatin Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Nystatin Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Nystatin Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Nystatin Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Nystatin Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Nystatin Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Nystatin Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Nystatin Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Nystatin Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Nystatin Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Nystatin Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Nystatin Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Nystatin Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Nystatin Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Nystatin Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Nystatin Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Nystatin Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Nystatin Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Nystatin Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Nystatin Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Nystatin Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Nystatin Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Nystatin Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Nystatin Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Nystatin Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Nystatin Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Nystatin Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Nystatin Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Nystatin Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Nystatin Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Nystatin Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Nystatin Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Nystatin Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Nystatin Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Nystatin Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Nystatin Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Nystatin Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Nystatin Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Nystatin Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Nystatin Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Nystatin Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Nystatin Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Nystatin Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Nystatin Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Nystatin Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Nystatin Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Nystatin Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Nystatin Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Nystatin Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Nystatin Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Nystatin Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Nystatin Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Nystatin Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Nystatin Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Nystatin Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Nystatin Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Nystatin Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Nystatin Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Nystatin Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Nystatin Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Nystatin Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Nystatin Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Nystatin Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Nystatin Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Nystatin Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Nystatin Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Nystatin Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Nystatin Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Nystatin Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Nystatin Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Nystatin Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Nystatin Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Nystatin Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Nystatin Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Nystatin Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Nystatin Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Nystatin Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Nystatin Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Nystatin Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Nystatin Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Nystatin Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Nystatin Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Nystatin Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Nystatin Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 3B Scientific
  2. 8.1.1 3B Scientific Company Information
  3. 8.1.2 3B Scientific Business Overview
  4. 8.1.3 3B Scientific Nystatin Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 3B Scientific Nystatin Product Portfolio
  6. 8.1.5 3B Scientific Recent Developments
  7. 8.2 BeiJing Hwrk Chemicals
  8. 8.2.1 BeiJing Hwrk Chemicals Company Information
  9. 8.2.2 BeiJing Hwrk Chemicals Business Overview
  10. 8.2.3 BeiJing Hwrk Chemicals Nystatin Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 BeiJing Hwrk Chemicals Nystatin Product Portfolio
  12. 8.2.5 BeiJing Hwrk Chemicals Recent Developments
  13. 8.3 Beijing NuoqiYa Biotechnology
  14. 8.3.1 Beijing NuoqiYa Biotechnology Company Information
  15. 8.3.2 Beijing NuoqiYa Biotechnology Business Overview
  16. 8.3.3 Beijing NuoqiYa Biotechnology Nystatin Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Beijing NuoqiYa Biotechnology Nystatin Product Portfolio
  18. 8.3.5 Beijing NuoqiYa Biotechnology Recent Developments
  19. 8.4 BEST-REAGENT
  20. 8.4.1 BEST-REAGENT Company Information
  21. 8.4.2 BEST-REAGENT Business Overview
  22. 8.4.3 BEST-REAGENT Nystatin Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 BEST-REAGENT Nystatin Product Portfolio
  24. 8.4.5 BEST-REAGENT Recent Developments
  25. 8.5 BOC Sciences
  26. 8.5.1 BOC Sciences Company Information
  27. 8.5.2 BOC Sciences Business Overview
  28. 8.5.3 BOC Sciences Nystatin Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 BOC Sciences Nystatin Product Portfolio
  30. 8.5.5 BOC Sciences Recent Developments
  31. 8.6 Fishfa Biogenics
  32. 8.6.1 Fishfa Biogenics Company Information
  33. 8.6.2 Fishfa Biogenics Business Overview
  34. 8.6.3 Fishfa Biogenics Nystatin Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Fishfa Biogenics Nystatin Product Portfolio
  36. 8.6.5 Fishfa Biogenics Recent Developments
  37. 8.7 HBCChem
  38. 8.7.1 HBCChem Company Information
  39. 8.7.2 HBCChem Business Overview
  40. 8.7.3 HBCChem Nystatin Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 HBCChem Nystatin Product Portfolio
  42. 8.7.5 HBCChem Recent Developments
  43. 8.8 J & K SCIENTIFIC
  44. 8.8.1 J & K SCIENTIFIC Company Information
  45. 8.8.2 J & K SCIENTIFIC Business Overview
  46. 8.8.3 J & K SCIENTIFIC Nystatin Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 J & K SCIENTIFIC Nystatin Product Portfolio
  48. 8.8.5 J & K SCIENTIFIC Recent Developments
  49. 8.9 LGM Pharma
  50. 8.9.1 LGM Pharma Company Information
  51. 8.9.2 LGM Pharma Business Overview
  52. 8.9.3 LGM Pharma Nystatin Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 LGM Pharma Nystatin Product Portfolio
  54. 8.9.5 LGM Pharma Recent Developments
  55. 8.10 Pure Chemistry Scientific
  56. 8.10.1 Pure Chemistry Scientific Company Information
  57. 8.10.2 Pure Chemistry Scientific Business Overview
  58. 8.10.3 Pure Chemistry Scientific Nystatin Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Pure Chemistry Scientific Nystatin Product Portfolio
  60. 8.10.5 Pure Chemistry Scientific Recent Developments
  61. 8.11 Toronto Research Chemicals
  62. 8.11.1 Toronto Research Chemicals Company Information
  63. 8.11.2 Toronto Research Chemicals Business Overview
  64. 8.11.3 Toronto Research Chemicals Nystatin Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Toronto Research Chemicals Nystatin Product Portfolio
  66. 8.11.5 Toronto Research Chemicals Recent Developments
  67. 8.12 Waterstone Technology
  68. 8.12.1 Waterstone Technology Company Information
  69. 8.12.2 Waterstone Technology Business Overview
  70. 8.12.3 Waterstone Technology Nystatin Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Waterstone Technology Nystatin Product Portfolio
  72. 8.12.5 Waterstone Technology Recent Developments
  73. 8.13 XiaoGan ShenYuan ChemPharm
  74. 8.13.1 XiaoGan ShenYuan ChemPharm Company Information
  75. 8.13.2 XiaoGan ShenYuan ChemPharm Business Overview
  76. 8.13.3 XiaoGan ShenYuan ChemPharm Nystatin Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 XiaoGan ShenYuan ChemPharm Nystatin Product Portfolio
  78. 8.13.5 XiaoGan ShenYuan ChemPharm Recent Developments
  79. 8.14 Olon S.p.A
  80. 8.14.1 Olon S.p.A Company Information
  81. 8.14.2 Olon S.p.A Business Overview
  82. 8.14.3 Olon S.p.A Nystatin Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Olon S.p.A Nystatin Product Portfolio
  84. 8.14.5 Olon S.p.A Recent Developments
  85. 8.15 Guangzhou Tosun Pharmaceutical
  86. 8.15.1 Guangzhou Tosun Pharmaceutical Company Information
  87. 8.15.2 Guangzhou Tosun Pharmaceutical Business Overview
  88. 8.15.3 Guangzhou Tosun Pharmaceutical Nystatin Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Guangzhou Tosun Pharmaceutical Nystatin Product Portfolio
  90. 8.15.5 Guangzhou Tosun Pharmaceutical Recent Developments
  91. 8.16 Pfizer
  92. 8.16.1 Pfizer Company Information
  93. 8.16.2 Pfizer Business Overview
  94. 8.16.3 Pfizer Nystatin Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Pfizer Nystatin Product Portfolio
  96. 8.16.5 Pfizer Recent Developments
  97. 8.17 Concord Biotech
  98. 8.17.1 Concord Biotech Company Information
  99. 8.17.2 Concord Biotech Business Overview
  100. 8.17.3 Concord Biotech Nystatin Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Concord Biotech Nystatin Product Portfolio
  102. 8.17.5 Concord Biotech Recent Developments
  103. 8.18 BrightGene Bio-Medical Technology
  104. 8.18.1 BrightGene Bio-Medical Technology Company Information
  105. 8.18.2 BrightGene Bio-Medical Technology Business Overview
  106. 8.18.3 BrightGene Bio-Medical Technology Nystatin Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 BrightGene Bio-Medical Technology Nystatin Product Portfolio
  108. 8.18.5 BrightGene Bio-Medical Technology Recent Developments
  109. 8.19 Antibiotice SA
  110. 8.19.1 Antibiotice SA Company Information
  111. 8.19.2 Antibiotice SA Business Overview
  112. 8.19.3 Antibiotice SA Nystatin Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Antibiotice SA Nystatin Product Portfolio
  114. 8.19.5 Antibiotice SA Recent Developments
  115. 8.20 Shanghai Minbiotech
  116. 8.20.1 Shanghai Minbiotech Company Information
  117. 8.20.2 Shanghai Minbiotech Business Overview
  118. 8.20.3 Shanghai Minbiotech Nystatin Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Shanghai Minbiotech Nystatin Product Portfolio
  120. 8.20.5 Shanghai Minbiotech Recent Developments
  121. 8.21 Zhejiang Huida Biotech
  122. 8.21.1 Zhejiang Huida Biotech Company Information
  123. 8.21.2 Zhejiang Huida Biotech Business Overview
  124. 8.21.3 Zhejiang Huida Biotech Nystatin Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Zhejiang Huida Biotech Nystatin Product Portfolio
  126. 8.21.5 Zhejiang Huida Biotech Recent Developments
  127. 8.22 Centrient Pharmaceuticals
  128. 8.22.1 Centrient Pharmaceuticals Company Information
  129. 8.22.2 Centrient Pharmaceuticals Business Overview
  130. 8.22.3 Centrient Pharmaceuticals Nystatin Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 Centrient Pharmaceuticals Nystatin Product Portfolio
  132. 8.22.5 Centrient Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Nystatin Value Chain Analysis
  2. 9.1.1 Nystatin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Nystatin Sales Mode & Process
  6. 9.2 Nystatin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Nystatin Distributors
  9. 9.2.3 Nystatin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst